Anterix Inc. ATEX
81.42
0.09
0.11%
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 23.2×
Follow ATEX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
4.19 | 5.01 | 7.87 | 29.33 |
P/S ratio |
67.71 | 68.75 | 109.78 | 279.04 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
285.76 | (49.30) | 45.99 | 960.74 | |
P/B ratio |
1.67 | 1.73 | 2.72 | 6.87 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
61.51 | 64.16 | 94.98 | 262.89 | |
EV/EBITDA |
3.64 | 4.54 | 6.54 | 25.84 | |
EV/Operating CF |
(14.02) | (14.33) | 112.04 | 173.06 | |
EV/FCF |
(7.22) | (7.33) | (28.41) | (95.78) | |
Quick Ratio |
1.35 | 1.06 | 3.03 | 4.13 | |
Current Ratio |
1.70 | 1.39 | 3.33 | 4.85 | |
Net Debt/EBITDA |
(0.64) | 3.30 | (4.94) | 800.07 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.02 | 0.02 | 0.02 | 0.02 | |
Operating CF/Net income |
0.03 | 1.25 | 0.84 | 8.52 | |
Capex/Depreciation |
(99.11) | (25.60) | (71.79) | (66.72) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
78.09% | 70.18% | 64.71% | 62.31% | |
Selling, General and Administrative Expense of Revenue |
634.47% | 641.77% | 565.83% | 589.12% | |
Intangible Assets out of Total Assets |
0.84 | 0.86 | 0.73 | 0.68 | |
Share Based Compensation of Revenue |
189.88% | 140.81% | 137.74% | 167.62% | |
Graham Net Nets |
(0.30) | (0.32) | (0.12) | (0.03) | |
Graham Number |
38.49 | 35.20 | 39.14 | 34.39 | |
Earnings Yield |
23.85% | 19.97% | 12.70% | 3.41% | |
Free Cash Flow Yield |
(12.58%) | (12.73%) | (3.05%) | (0.98%) | |
Revenue per Share |
0.08 | 0.08 | 0.10 | 0.10 | |
Operating CF per Share |
0.08 | (0.44) | 0.83 | 0.11 | |
Capex per Share |
(0.71) | (0.14) | (0.40) | (0.35) | |
Free Cash Flow per Share |
(0.63) | (0.59) | 0.43 | (0.25) | |
Cash per Share |
2.09 | 1.58 | 5.27 | 6.08 | |
Shareholders Equity per Share |
12.86 | 12.63 | 14.04 | 14.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.86 | 12.63 | 14.04 | 14.97 | |
Free Cash Flow |
(11.78) | (10.93) | 8.13 | (4.69) | |
Working Capital |
24.18 | 14.05 | 83.99 | 121.53 | |
Capital Expenditures |
(13.18) | (2.66) | (7.39) | (6.74) | |
Net Current Asset Value |
(121.22) | (130.99) | (82.90) | (59.05) | |
EV/EBIT |
3.66 | 4.56 | 6.57 | 26.00 | |
Capex to Sales |
8.49 | 1.69 | 3.78 | 3.44 | |
Net Profit Margin |
3,449.48% | (419.64%) | 945.86% | 12.26% | |
Price to Operating Income |
4.03 | 4.89 | 7.60 | 27.59 | |
| Other line items | |||||
Average Receivables |
9.81 | 8.42 | 10.34 | 9.80 | |
Average Payables |
10.95 | 11.95 | 12.05 | 9.27 | |
Average Assets |
368.81 | 371.84 | 399.16 | 428.75 | |
Average Common Equity |
189.71 | 190.35 | 209.46 | 235.28 |
Columns are period end dates